Cyclobenzaprine Hydrochloride
NDC 24979-036, Cyclobenzaprine Hydrochloride, capsule, extended release, from Upsher-Smith Laboratories, LLC.
- Product NDC
- 24979-036
- Status
- Listed
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA091281
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24979-036 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE30 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24979-036-04 | 24979003604 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (24979-036-04) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/14f64ceb-ea5c-4d7c-a0c1-3f6a64847290NADAC price for package 24979003604
GET /v1/drugs/nadac/24979003604
Use it
Look up 24979-036 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24979-036 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24979-036. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.